1.
Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study
by Gershon, Andrea S, Dr
The Lancet (British edition), 2011, Vol.378 (9795), p.991-996
2.
Depression, anxiety and health status after hospitalisation for COPD: A multicentre study in the Nordic countries
by Gudmundsson, Gunnar
Respiratory medicine, 2006, Vol.100 (1), p.87-93
3.
Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country
by Musafiri, Sanctus
Respiratory medicine, 2011, Vol.105 (11), p.1596-1605
4.
Chronic obstructive pulmonary disease
by Decramer, Marc, Prof
The Lancet (British edition), 2012, Vol.379 (9823), p.1341-1351
5.
Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
by Andréjak, Claire
Thorax, 2013-03, Vol.68 (3), p.256-262
6.
Risk factors and early origins of chronic obstructive pulmonary disease
by Postma, Dirkje S, Prof
The Lancet (British edition), 2015-03-07, Vol.385 (9971), p.899-909
7.
Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action
by Guan, Wei-Jie, PhD
The Lancet (British edition), 2016, Vol.388 (10054), p.1939-1951
8.
Asthma in older adults
by Gibson, Peter G, Prof
The Lancet (British edition), 2010, Vol.376 (9743), p.803-813
9.
Asthma–COPD overlap 2015: now we are six
by Gibson, Peter G
Thorax, 2015-07, Vol.70 (7), p.683-691
10.
Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China
by Liu, Sha
Thorax, 2017-09, Vol.72 (9), p.788-795
11.
Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalisations in Sweden
by Hemminki, K
Journal of epidemiology and community health (1979), 2008-05, Vol.62 (5), p.398-401
12.
Global burden of COPD: risk factors, prevalence, and future trends
by Mannino, David M, Dr
The Lancet (British edition), 2007, Vol.370 (9589), p.765-773
13.
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome
by Guinea, J
Clinical microbiology and infection, 2010-07, Vol.16 (7), p.870-877
14.
Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation
by Jones, Sarah E
Thorax, 2015-03, Vol.70 (3), p.213-218
15.
Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years
by Bhatt, Surya P
Thorax, 2018-05, Vol.73 (5), p.414-421
16.
The association between childhood asthma and adult chronic obstructive pulmonary disease
by Tai, Andrew
Thorax, 2014-09, Vol.69 (9), p.805-810
17.
Gender differences in COPD: are women more susceptible to smoking effects than men?
by Sørheim, Inga-Cecilie
Thorax, 2010-06, Vol.65 (6), p.480-485
18.
Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease
by Ghebre, Michael A., MSc
Journal of allergy and clinical immunology, 2014, Vol.135 (1), p.63-72.e10
19.
Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies
by Matte, Darlan L
Respiratory medicine, 2016, Vol.117, p.154-161
20.
COPD, emphysema and the onset of lung cancer. A systematic review
by Mouronte-Roibás, Cecilia
Cancer letters, 2016, Vol.382 (2), p.240-244
